These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 3621111
21. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Wolter F, Turchanowa L, Stein J. Carcinogenesis; 2003 Mar; 24(3):469-74. PubMed ID: 12663506 [Abstract] [Full Text] [Related]
23. Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas. McGarrity TJ, Peiffer LP, Bartholomew MJ, Pegg AE. Cancer; 1990 Oct 01; 66(7):1539-43. PubMed ID: 2208006 [Abstract] [Full Text] [Related]
24. Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes. Elitsur Y, Moshier JA, Murthy R, Barbish A, Luk GD. Life Sci; 1992 Oct 01; 50(19):1417-24. PubMed ID: 1573975 [Abstract] [Full Text] [Related]
27. Relationship of ornithine decarboxylase activity and human colon tumorigenesis. Takami H, Koudaira H, Kodaira S. Jpn J Clin Oncol; 1994 Jun 01; 24(3):141-3. PubMed ID: 8007423 [Abstract] [Full Text] [Related]
28. [Ornithine decarboxylase activity and polyamine content in human adenocarcinomas of the stomach and large intestine]. Berdinskikh NK, Zaletok SP, Bobro LI, Ignatenko NA. Eksp Onkol; 1988 Jun 01; 10(6):39-41. PubMed ID: 3243193 [Abstract] [Full Text] [Related]
30. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Cañizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Peñafiel R. Clin Cancer Res; 1999 Aug 01; 5(8):2035-41. PubMed ID: 10473083 [Abstract] [Full Text] [Related]
31. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia. Braverman DZ, Stankiewicz H, Goldstein R, Patz JK, Morali GA, Jacobsohn WZ. Am J Gastroenterol; 1990 Jun 01; 85(6):723-6. PubMed ID: 2353692 [Abstract] [Full Text] [Related]
32. Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasia. Koo HB, Sigurdson ER, Daly JM, Berenson M, Groshen S, Decosse JJ. J Surg Oncol; 1988 Aug 01; 38(4):240-3. PubMed ID: 3411968 [Abstract] [Full Text] [Related]
36. Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus. Li W, Liu X, Wang W, Sun H, Hu Y, Lei H, Liu G, Gao Y. Prostate; 2008 Sep 01; 68(12):1354-61. PubMed ID: 18548481 [Abstract] [Full Text] [Related]
37. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study. Freitas D, Goulão MH, Camacho E, Figueiredo P, Ministro P, Ferreira M, Portela F, Andrade P, Donato A, Martins MI. Hepatogastroenterology; 2002 Sep 01; 49(47):1269-74. PubMed ID: 12239922 [Abstract] [Full Text] [Related]
39. Dissimilar activation patterns of the carcinogen dimethylhydrazine (DMH) on intracellular polyamine metabolism in various organs. Löser C, Starp F, Fölsch UR. Z Gastroenterol; 1996 Dec 01; 34(12):801-8. PubMed ID: 9017896 [Abstract] [Full Text] [Related]
40. Mucosal ornithine decarboxylase, polyamines, and hyperplasia in infected intestine. Wang JY, Johnson LR, Tsai YH, Castro GA. Am J Physiol; 1991 Jan 01; 260(1 Pt 1):G45-51. PubMed ID: 1846274 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]